Dipasquale G - Search Results

1

Urinary toxicity after salvage re-irradiation for prostate cancer local failure after definitive radiotherapy: a clinical and dosimetric prognostic factors analysis.

Dipasquale G, Zilli T, Fiorino C, Achard V, Rouzaud M, Miralbell R. Dipasquale G, et al. J Contemp Brachytherapy. 2022 Jun;14(3):222-226. doi: 10.5114/jcb.2022.117124. Epub 2022 Jun 14. J Contemp Brachytherapy. 2022. PMID: 36199992 Free PMC article.

2

Open low-field magnetic resonance imaging for target definition, dose calculations and set-up verification during three-dimensional CRT for glioblastoma multiforme.

Weber DC, Wang H, Albrecht S, Ozsahin M, Tkachuk E, Rouzaud M, Nouet P, Dipasquale G. Weber DC, et al. Among authors: dipasquale g. Clin Oncol (R Coll Radiol). 2008 Mar;20(2):157-67. doi: 10.1016/j.clon.2007.09.001. Epub 2007 Oct 22. Clin Oncol (R Coll Radiol). 2008. PMID: 17936601

3

[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma.

Weber DC, Zilli T, Buchegger F, Casanova N, Haller G, Rouzaud M, Nouet P, Dipasquale G, Ratib O, Zaidi H, Vees H, Miralbell R. Weber DC, et al. Among authors: dipasquale g. Radiat Oncol. 2008 Dec 24;3:44. doi: 10.1186/1748-717X-3-44. Radiat Oncol. 2008. PMID: 19108742 Free PMC article. Clinical Trial.

4

Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study.

Ares C, Popowski Y, Pampallona S, Nouet P, Dipasquale G, Bieri S, Ozsoy O, Rouzaud M, Khan H, Miralbell R. Ares C, et al. Among authors: dipasquale g. Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):656-63. doi: 10.1016/j.ijrobp.2008.11.023. Epub 2009 Feb 26. Int J Radiat Oncol Biol Phys. 2009. PMID: 19250768

5

RapidArc, intensity modulated photon and proton techniques for recurrent prostate cancer in previously irradiated patients: a treatment planning comparison study.

Weber DC, Wang H, Cozzi L, Dipasquale G, Khan HG, Ratib O, Rouzaud M, Vees H, Zaidi H, Miralbell R. Weber DC, et al. Among authors: dipasquale g. Radiat Oncol. 2009 Sep 9;4:34. doi: 10.1186/1748-717X-4-34. Radiat Oncol. 2009. PMID: 19740429 Free PMC article.

6

Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study.

Weber DC, Casanova N, Zilli T, Buchegger F, Rouzaud M, Nouet P, Vees H, Ratib O, Dipasquale G, Miralbell R. Weber DC, et al. Among authors: dipasquale g. Radiother Oncol. 2009 Dec;93(3):586-92. doi: 10.1016/j.radonc.2009.08.043. Epub 2009 Sep 24. Radiother Oncol. 2009. PMID: 19782417

7

Unilateral radiotherapy for tonsil cancer: potential dose distribution optimization with a simple two-field intensity-modulated radiation therapy beam arrangement.

Zilli T, Nouet P, Casanova N, Betz M, Dipasquale G, Rouzaud M, Miralbell R, Ozsahin M. Zilli T, et al. Among authors: dipasquale g. Radiother Oncol. 2010 Mar;94(3):334-8. doi: 10.1016/j.radonc.2009.11.009. Epub 2009 Dec 18. Radiother Oncol. 2010. PMID: 20022393

8

Dose escalation study with two different hypofractionated intensity modulated radiotherapy techniques for localized prostate cancer: acute toxicity.

Zilli T, Rouzaud M, Jorcano S, Dipasquale G, Nouet P, Toscas JI, Casanova N, Wang H, Escude L, Molla M, Linero D, Weber DC, Miralbell R. Zilli T, et al. Among authors: dipasquale g. Technol Cancer Res Treat. 2010 Jun;9(3):263-70. doi: 10.1177/153303461000900305. Technol Cancer Res Treat. 2010. PMID: 20441236 Free article. Clinical Trial.

9

Twice-weekly hypofractionated intensity-modulated radiotherapy for localized prostate cancer with low-risk nodal involvement: toxicity and outcome from a dose escalation pilot study.

Zilli T, Jorcano S, Rouzaud M, Dipasquale G, Nouet P, Toscas JI, Casanova N, Wang H, Escudé L, Mollà M, Linero D, Weber DC, Miralbell R. Zilli T, et al. Among authors: dipasquale g. Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):382-9. doi: 10.1016/j.ijrobp.2010.05.057. Epub 2010 Sep 29. Int J Radiat Oncol Biol Phys. 2011. PMID: 20884129

10

Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CT.

Vees H, Steiner C, Dipasquale G, Chouiter A, Zilli T, Velazquez M, Namy S, Ratib O, Buchegger F, Miralbell R. Vees H, et al. Among authors: dipasquale g. Radiat Oncol. 2012 Aug 8;7:134. doi: 10.1186/1748-717X-7-134. Radiat Oncol. 2012. PMID: 22873771 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters